Cochrane South Africa has announced the appointment of Charles Shey Wiysonge as its new Director, effective December 2016.
Originally trained as a physician, Professor Wiysonge has also completed extensive postgraduate training in epidemiology, evidence-based health care, and vaccinology. His previous roles have included serving as Senior Research Officer with the Joint United Nations Programme on HIV/AIDS in Geneva, Senior Scientist with the South African Medical Research Council, Senior Researcher and Programme Manager for the University of Cape Town’s Vaccines for Africa Initiative, and the Deputy Director of the Centre for Evidence-Based Health Care at Stellenbosch University. His association with Cochrane dates back to 2001, when he became the inaugural recipient of the Aubrey Sheiham Public Health and Primary Care Scholarship (from 2014 The Aubrey Sheiham Evidence-based Health Care in Africa Leadership Award). In addition to authoring multiple Cochrane Reviews, since 2014 Professor Wiysonge has been on the staff of Cochrane South Africa as Chief Specialist Scientist.
The Founding Director of Cochrane South Africa, Jimmy Volmink, will be stepping down from managing day-to-day operations at the Centre, but will continue to serve as Chair of the Global Organizing Committee for the 2017 Global Evidence Summit.
Brought to you by Scope e-Knowledge Center, a world-leading provider of metadata services, abstraction, indexing, entity extraction and knowledge organisation models (Taxonomies, Thesauri and Ontologies).
